PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
4 September 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Novo Nordisk Acquires Ziylo

The acquisition will support Novo Nordisk's development of glucose-responsive insulins.
/ read more /


Viewpoint: Regulators Hinder Process Innovation

Girish Malhotra argues in CPhI Annual Report that shorter approval times and financial incentives are needed to promote manufacturing improvements.
/ read more /

Check out the PharmTech Europe Supplement on APIs, Excipients, and Manufacturing, includes the CPhI Worldwide Planning Guide.

August Supplement 2018
subscribe
advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe

Industry News

CEPI, IDT Partner to Develop MERS Vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
/ read more /


bioLIVE Survey Ranks Top Bioprocessing Nations

Preliminary survey results rank the United States, Germany, and Japan as tier-one nations for bioprocessing performance and potential.
/ read more /


More Industry News
advertisement

Regulatory News

Quality Failures at Foreign Manufacturers Prompt Warnings and Recalls

A wave of potentially impure drugs and APIs from China, India, and other foreign firms has prompted recalls and FDA warning letters.
/ read more /


FDA Says No Need to Compound from Bumetanide, Nicardipine hydrochloride, and Vasopressin

FDA proposed in a Federal Register notice that bumetanide, nicardipine hydrochloride, and vasopressin should not be included on the list of bulk drug substances that outsourcing facilities may use in compounding.
/ read more /


More Regulatory News

Bio/Pharma News

Pfizer Recalls Children's Advil

Pfizer Consumer Healthcare is recalling one lot of Children's Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle because of improperly marked dosage cups.
/ read more /


EC Approves Novartis' Kymriah CAR-T Cell Therapy

The European Commission (EC) has approved Novartis' chimeric antigen receptor T cell (CAR-T) cell therapy Kymriah for the treatment of B-cell acute lymphoblastic leukemia and relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
/ read more /


More Bio/Pharma News

Supplier News

ABEC Expands Equipment Supply Capability

The company is certified as a manufacturer of pressure vessels and components for use in China.
/ read more /

 

Sanner Expands Production in Hungary

Pharma packaging manufacturer Sanner has expanded capacity at its site in Budapest, Hungary.
/ read more /


More Supplier News

FEATURED TOPICS

OUTSOURCING

What Ifs in the Five-Year Plan

Heightened uncertainty means CDMO executives need to play out planning scenarios.
/ read more /

 

FORMULATION

Designing Combination Products

API can be mixed with silicone and other polymers to create drug-delivery combination products.
/ read more /

MANUFACTURING

Reducing Cleanroom Complexities and Cost

Why shouldn't biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
/ read more /

QUALITY SYSTEMS

Lifecycle-Based Process Validation Emphasizes the Need for Continued Process Verification

A year's worth of FDA warning letters suggest that API and finished drug manufacturers should strengthen their approach to continued process verification.
/ read more /


Events

SMi's 9th Annual Biosimilars & Biobetters Conference

London, United Kingdom

26–27 September 2018

CPhI 2018

Madrid, Spain

9–11 October 2018

Cell & Gene Therapy 2018

London, United Kingdom

10–11 October 2018

PDA Europe Pharmaceutical Microbiology

Berlin, Germany

15–16 October 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise